Brief: Tarsus Announces Pricing Of Upsized $75.6 Mln Public Offering Of Common Stock
03/05/2022 12:35
May 3 (Reuters) - Tarsus Pharmaceuticals Inc TARS.O :
* TARSUS ANNOUNCES PRICING OF UPSIZED $75.6 MILLION
UNDERWRITTEN
PUBLIC OFFERING OF COMMON STOCK
* TARSUS PHARMACEUTICALS INC - PRICING OF AN UPSIZED
UNDERWRITTEN
PUBLIC OFFERING AT A PUBLIC OFFERING PRICE OF $13.50 PER SHARE
Source text for Eikon: ID:nGNX9DpH4M
Further company coverage: TARS.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Tarsus Pharmaceuticals
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Tarsus Pharmaceuticals Files For Offering Of Up To 2.91 Million Shares Of Common Stock By Selling Stockholders
U.S. RESEARCH ROUNDUP-Argan, Mastec, Oracle
Tarsus Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition (updated)